QC
DERM icon

Quadrature Capital’s Journey Medical DERM Stock Holding History

Quadrature Capital’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$204K Buy
+28,841
New +$165K ﹤0.01% 1354
2025
Q3 		– Sell
-13,181
Closed -$94.4K – 1135
2025
Q2 		$94.4K Buy
+13,181
New +$91.1K ﹤0.01% 898

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAIM
Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Quadrature Capital's DERM Position: Q2 2026 in Review

Quadrature Capital opened a new position in Journey Medical (DERM) in Q2 2026: 28,841 shares worth $204K. The stake represents ﹤0.01% of the portfolio and ranks #1354 among its holdings. This is a return to the name: Quadrature Capital previously reported a position in DERM as recently as Q2 2025.

Quadrature Capital first reported a position in DERM in Q2 2025 and has held it in 2 quarters since. 71 funds tracked by Wall St. Rank hold DERM as of Q2 2026.

  • Quadrature Capital held 28,841 shares of Journey Medical worth $204K as of Q2 2026.
  • Journey Medical was a new Quadrature Capital position in Q2 2026.
  • Journey Medical made up ﹤0.01% of Quadrature Capital's portfolio in Q2 2026, its #1354 holding.
  • Quadrature Capital first reported a position in Journey Medical in Q2 2025 and has held it in 2 quarters since.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.